Navigation Links
Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer
Date:9/20/2007

NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders and diseases, announced today that complete enrollment of its Phase II clinical trial of Atiprimod to treat low to intermediate grade neuroendocrine carcinoma (advanced carcinoid cancer) was accomplished ahead of schedule. The trial, designed to enroll 40 patients, presently has patients enrolled at seven clinical sites in the U.S., and was closed to further enrollment with the addition of the 40th patient.

"This Atiprimod trial was initiated in November, 2006 and we are pleased with the tremendous pace of enrollment that we experienced," said Dr. Gary S. Jacob, Chief Executive Officer of Callisto. "We have patients who have now been on our drug for as long as 11 months, and we expect that by January of 2008 the bulk of patients will have been treated for 6 months or more on our drug. We anticipate at that time releasing interim data from the trial as well as planning for a meeting with FDA on the design of a registration trial."

The primary objective of the Phase II clinical trial was to evaluate efficacy of Atiprimod in patients with low to intermediate grade neuroendocrine carcinoma who have metastatic or unresectable cancer and who have progression of their disease despite standard therapy (octreotide). Patients, after signing an informed consent, were required to complete two weeks of a symptoms diary to establish their symptoms baseline before commencing Atiprimod dosing. Efficacy evaluations include the measure of target lesions (per RECIST), and the quantization of symptom relief. Further details of this trial can be found at http://www.clinicaltrials.gov.

About Atiprimod

Atiprimod is an orally bio-available small molecule drug that displays multiple mechanisms of action. The drug
'/>"/>

SOURCE Callisto Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Callisto Pharmaceuticals Announces Publication of Research Article on Atiprimod Preclinical Studies in Mantle Cell Lymphoma
2. Callisto Intends to Move Guanilib into Clinical Trials in Ulcerative Colitis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... September 19, 2014 Aufgrund ... den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt auch ... PDF, verfügbar unter pharmaserialisation.com , zeigt die ... jeweils in Kraft treten. Für international ... länger um das "ob", sondern darum, "wann" sie ...
(Date:9/19/2014)... , Sept. 19, 2014  Over 200 runners participated ... to Benefit the Radiation Oncology Institute (ROI), hosted by ... Golden Gate Park in San Francisco.  ... , CEO of Radiation Business Solutions, "but at ... raised over $70,000 for the ROI this year. This ...
(Date:9/19/2014)... Sept. 19, 2014 Intarcia Therapeutics, Inc. ... data for its lead candidate ITCA 650 (continuous subcutaneous ... high baseline HbA1c levels at the 50 th ... of Diabetes (EASD). Data from the open-label, phase 3 ... blood sugar in patients with poorly controlled type 2 ...
Breaking Medicine Technology:Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
... Ill., April 7, 2011 MinuteClinic, the ... CVS ), has entered into a clinical affiliation ... enhance the high quality, affordable health care services provided ... It is the largest clinical collaboration between a regional ...
... A study published in the journal ... third-largest health system, has achieved remarkable results in eliminating ... and keeping patients safe.  In 2003, Ascension Health set ... Ascension Health has seen consistent improvement over the eight ...
Cached Medicine Technology:New Affiliation Between MinuteClinic and Advocate Health Care Increases Access to Medical Services in Chicagoland 2New Affiliation Between MinuteClinic and Advocate Health Care Increases Access to Medical Services in Chicagoland 3New Affiliation Between MinuteClinic and Advocate Health Care Increases Access to Medical Services in Chicagoland 4Study Highlights Successes of Ascension Health Quality Initiative 2
(Date:9/19/2014)... Hills, CA (PRWEB) September 19, 2014 Bedros ... fastest-selling fitness boot camp in the country. He’s also considered ... thousands of clients, coaching celebrity trainers and serving as a ... knows marketing, and he says that becoming an integral part ... success. , “One of the things that Fit Body Boot ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Quincy ... Theirl, a functional neurologist in private practice in ... of Prevagen Professional in older adults with mild ... – Focus On Brain Health conference on ... is the strongest formula available of the jellyfish ...
(Date:9/19/2014)... September 19, 2014 ShopRite has launched ... School -- with the 2014-2015 school year. The new ... schools via eBoxTops and special donations throughout the year. ... school by registering their ShopRite Price Plus Card at ... for their favorite school. By using their Price Plus ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Atlantic Information ... the authoritative AIS’s Directory of Health Plans — is ... Trends and Data: 2014-2015. The latest edition of the ... re-shaping the health care industry. , With valuable ... issues — from benefit design and management strategies to ...
(Date:9/19/2014)... B. E. Smith, the only full-service leadership ... retained to lead a national chief operating officer ... Rockaway, N.Y. The top executive search firm in the ... than 900 healthcare executives into organizations. , St. ... hospital serving the Rockaway and the Five Towns communities. ...
Breaking Medicine News(10 mins):Health News:New Post from Boot Camp Marketing Expert Bedros Keuilian Explains Importance of Becoming Part of the Community 2Health News:New Post from Boot Camp Marketing Expert Bedros Keuilian Explains Importance of Becoming Part of the Community 3Health News:Prevagen Research Presented at Healthcare Practitioner Conference 2Health News:ShopRite to Donate Up to $1 Million to Local Schools 2Health News:New Book from Atlantic Information Provides Insights Into Trends in the Health Care Industry 2Health News:St. John’s Episcopal Hospital Retains B. E. Smith to Recruit New COO 2Health News:St. John’s Episcopal Hospital Retains B. E. Smith to Recruit New COO 3
... Cholesterol-lowering meds seem to shield against troublesome complication, study ... patients who take cholesterol-lowering statins before cardiac surgery may ... study finds. , Depending on variables such as ... 47 percent of people experience this condition of confusion ...
... mechanics can lead to pain and stiffness , , THURSDAY, Dec. 25 ... back. , To ease the backaches that may have come ... and stretching and straining to put up holiday decorations -- and that ... Association offers a 10-step guide: , Zero ...
... these cells more closely mimic those of humans , , ... found a formula to capture indefinitely the basic embryonic ... cells. , If the findings hold up, scientists ... readily produced, genetically altered strains of rats. As humans ...
... conflicting news reports on the ongoing Baxter Heparin blood thinner controversy. ... of death among several patients, but the agency has also alleged ... patients. , ... Denver, CO (PRWEB) December 25, 2008 ...
... Weber Denture Liner kit is designed to answer questions often ... my loose denture fit better, give me more comfort and ... use of this new always-soft Weber Denture Liner. All ... fit better with this new (Patent Pending) invention. The Weber ...
... at risk for dementia, Parkinsons, researchers say , , WEDNESDAY, ... causes them to kick or cry out during deep sleep ... new Canadian study suggests. , "It,s basically a disorder where ... Dr. Ronald B. Postuma, of McGill University in Montreal. "When ...
Cached Medicine News:Health News:Tips to Ease an Aching Back 2Health News:Scientists May Isolate Stem Cells From Rats, Other Mammals 2Health News:LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers 2Health News:LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers 3Health News:LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers 4Health News:New Product Makes Loose Dentures Fit Better 2Health News:New Product Makes Loose Dentures Fit Better 3Health News:Sleep Disorder Could Signal Neurological Disease 2
Anesthetists Precordial Kit incudes one set of 4 chromed plated chest pieces, a reusable monoscope of your choice, and 20 precordial adhesive discs....
Precordial Chestpieces are manufactured from chrome plated brass. Provides a hollow design with deep sound chambers for optimum acoustics....
Adhesive discs sold on rolls of 100, 250, or 1000 each. Manufactured from non-latex medical grade adhesives & material. One size fits all chest pieces....
For accurately monitoring heart and breath sounds....
Medicine Products: